431 related articles for article (PubMed ID: 26701983)
41. Multi-Omics Integrated Analysis of the Protective Effect of EZH2 Inhibition in Mice with Renal Ischemia-Reperfusion Injury.
Zou S; Chen J; Zhou P; Xue M; Wu M; Wang L
Kidney Blood Press Res; 2024; 49(1):196-207. PubMed ID: 38368866
[TBL] [Abstract][Full Text] [Related]
42. Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway.
Zhou T; Sun Y; Li M; Ding Y; Yin R; Li Z; Xie Q; Bao S; Cai W
Cell Death Dis; 2018 May; 9(6):590. PubMed ID: 29789597
[TBL] [Abstract][Full Text] [Related]
43. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
[TBL] [Abstract][Full Text] [Related]
44. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
[TBL] [Abstract][Full Text] [Related]
45. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.
Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC
Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318
[TBL] [Abstract][Full Text] [Related]
46. PTEN improve renal fibrosis in vitro and in vivo through inhibiting FAK/AKT signaling pathway.
Du Y; Liu P; Chen Z; He Y; Zhang B; Dai G; Xia W; Liu Y; Chen X
J Cell Biochem; 2019 Oct; 120(10):17887-17897. PubMed ID: 31144376
[TBL] [Abstract][Full Text] [Related]
47. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
48. Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway.
Wen L; Tao SH; Guo F; Li LZ; Yang HL; Liang Y; Zhang LD; Ma L; Fu P
Acta Pharmacol Sin; 2022 Aug; 43(8):2067-2080. PubMed ID: 34937916
[TBL] [Abstract][Full Text] [Related]
49. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of enhancer of zeste homolog 2 prevents corneal myofibroblast transformation in vitro.
Liao K; Cui Z; Zeng Y; Liu J; Wang Y; Wang Z; Tang S; Chen J
Exp Eye Res; 2021 Jul; 208():108611. PubMed ID: 33992624
[TBL] [Abstract][Full Text] [Related]
51. Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH.
Wasson CW; Abignano G; Hermes H; Malaab M; Ross RL; Jimenez SA; Chang HY; Feghali-Bostwick CA; Del Galdo F
Ann Rheum Dis; 2020 Apr; 79(4):507-517. PubMed ID: 32041748
[TBL] [Abstract][Full Text] [Related]
52. EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation.
Song S; Zhang R; Mo B; Chen L; Liu L; Yu Y; Cao W; Fang G; Wan Y; Gu Y; Wang Y; Li Y; Yu Y; Wang Q
J Mol Cell Cardiol; 2019 Oct; 135():119-133. PubMed ID: 31408621
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway.
Shi Y; Li J; Chen H; Hu Y; Tang L; Wang Y; Zang X; Ma X; Huang G; Zhou X; Tao M; Lv Z; Chen S; Qiu A; Zhuang S; Liu N
J Pathol; 2022 Oct; 258(2):164-178. PubMed ID: 35792675
[TBL] [Abstract][Full Text] [Related]
54. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.
Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8687-92. PubMed ID: 15173588
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of transforming growth factor β1 signaling in resident interstitial cells attenuates profibrotic gene expression and preserves erythropoietin production during experimental kidney fibrosis in mice.
Fuchs MAA; Broeker KAE; Schrankl J; Burzlaff N; Willam C; Wagner C; Kurtz A
Kidney Int; 2021 Jul; 100(1):122-137. PubMed ID: 33705825
[TBL] [Abstract][Full Text] [Related]
57. EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin.
Chen SQ; Li JQ; Wang XQ; Lei WJ; Li H; Wan J; Hu Z; Zou YW; Wu XY; Niu HX
Cell Div; 2020; 15():8. PubMed ID: 32508971
[TBL] [Abstract][Full Text] [Related]
58. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.
Zhang Q; Dong P; Liu X; Sakuragi N; Guo SW
Sci Rep; 2017 Jul; 7(1):6804. PubMed ID: 28754964
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis.
Sasaki K; Doi S; Nakashima A; Irifuku T; Yamada K; Kokoroishi K; Ueno T; Doi T; Hida E; Arihiro K; Kohno N; Masaki T
J Am Soc Nephrol; 2016 Jan; 27(1):203-15. PubMed ID: 26045091
[TBL] [Abstract][Full Text] [Related]
60. AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3.
Liebisch M; Wolf G
Am J Nephrol; 2020; 51(9):676-692. PubMed ID: 32854097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]